Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

CancerScan Smart pathology slide scanner for diagnosis and patient-specific treatment recommendation in oncology

Coordinator
Agencia Estatal Consejo Superior De Investigaciones Cientificas, Spain
Runs
1 August 2025 to 31 July 2028
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
8 organisations in 6 countries
Type
European Innovation Council
Grant agreement
101186829

What the project is doing

In the project's own words, from its summary on CORDIS.

Our long-term vision is to develop a smart digital pathology slide scanner that can (semi)automatically generate a patient-specific tumour digital twin and simulate various drug treatments on such twin. The digital twin will be generated by combining slide-level multi-omics profiling of patients’ biopsies with other standard clinical data and will be hardware-embedded within a slide scanner. This foundational architecture involves five pillars: experimental mapping of tumor communication, reconstruction of Biomedical Knowledge Graphs (KG) based on experimental data, identification of structural and temporal properties of communication networks, development of a mathematical framework for modeling treatment effects on a tumor, and the design of a novel hardware acceleration architecture for a medical digital twin.

As a model system, we will use pancreatic cancer, combining in vitro experiments with clinical data. We will analyze how tumor microenvironment composition affects cellular crosstalk and drug efficacy by developing, growing, and treating a series of tumor organoids with different TME compositions, and performing a detailed molecular analysis of samples. Clinical validation will involve matching organoid and patient biopsy structures, ensuring relevance and applicability of our findings, thanks to the participation of a hospital as a third party.

This project is the initial step towards a platform assisting doctors in improving the diagnosis and assessment of drug treatment efficacy for individual cancer patients so that each patient gets the best possible drug, with the best possible treatment regimen.

Topics

Who is involved

OrganisationCityCountryRole
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainCoordinator
Minds & Sparks GmbHWienAustriaParticipant
Universitaet BielefeldBielefeldGermanyParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Politecnico Di MilanoMilanoItalyParticipant
Faculdade De Ciencias Da Universidade De LisboaLisboaPortugalThird party
Fciencias.id - Associacao Para a Investigacao E Desenvolvimento De CienciasLisbonPortugalParticipant
Neovivum Technologies Doo Novi SadNovi SadSerbiaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS